Evaluating Microarray Pharmacogenetic Testing in Cancer Patients

Evaluating Microarray Pharmacogenetic Testing in Cancer Patients
Conditions: Cancer; Gastrointestinal Cancer

Interventions: Genetic: Pharmacogenomic Testing with the “Global Diversity Array with Enhanced PGx”

Sponsors: Wake Forest University Health Sciences; Atrium Health Levine Cancer Institute

Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

July 7, 2024Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Comments